Berry Genomics Competitors and Similar CompaniesClear all
Berry Genomics's competitors and similar companies include ZAI Lab and SEASUN BIOMATERIALS.
 Berry Genomics Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications, primarily in genetic testing and oncology testing. |  ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. |  SEASUN BIOMATERIALS SEASUN BIOMATERIALS (시선바이오머티리얼스) is a company that provides solutions for diagnosing genetic disorders and cancer genome. | |
Founding Date | Founding Date 2010 | Founding Date 2014 | Founding Date 2012 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations CN HQ | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations KR HQ |
Employees | Employees 1,402 | Employees 1,869 | Employees N/A |
Valuation ($) | Valuation ($) 460.5 m | Valuation ($) 3.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1b (FY, 2024) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥572.9m (FY, 2024) | Cost of goods $190.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥494m (FY, 2024) | Gross profit $269.6m (FY, 2025) | Gross profit N/A |
Net income | Net income (¥188.2m) (FY, 2024) | Net income ($175.5m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 145.7m | Total funding raised $ 985m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ZAI Lab
HQ
CN
Employees
1,869
Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
View companySEASUN BIOMATERIALS
HQ
KR
SEASUN BIOMATERIALS (시선바이오머티리얼스) is a company that provides solutions for diagnosing genetic disorders and cancer genome.
View company